Skip to content
Aussie8 – Lifestyle
Author:
Addex Therapeutics
Addex Convenes Annual General Meeting 2026
June 5, 2026
Addex Reports Full Year 2025 Financial Results and Provides Corporate Update
April 30, 2026
Addex GABAB PAM Candidate Demonstrates Solid Anti-Tussive Activity in Bleomycin IPF-Related Chronic Cough Model
April 29, 2026
Addex Spin-Out Company Neurosterix on Track to Complete Phase 1 Clinical Study of NTX-253 for Schizophrenia in Q2 2026
April 23, 2026
Addex GABAB PAM Candidate Demonstrates Robust Anti-Tussive Activity in Non-Human Primate Chronic Cough Model
April 21, 2026